Novartis Venture Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 343

  • Portfolio
  • 48

  • Exits
  • 166

Exits

Novartis Venture Fund General Information

Company Description

Founded in 1996, Novartis Venture Fund is a corporate venture capital investment arm of Novartis based in Basel, Switzerland. The firm has a regional office in Cambridge, Massachusetts. The firm seeks to invest in the life sciences, oncology, biotechnology, and digital health sectors.

Business Details

Website
www.nvfund.com
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • Postfach
  • 4002 Basel
  • Switzerland
+41 061 000 00 00

Novartis Venture Fund Investments (343)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
FundaMental Pharma 11-Apr-2024 Seed Round 000.00 Pharmaceuticals Generating Revenue 0000000 00000000000 00.0
ImmPACT Bio 01-Apr-2024 00000 00000 00000 Drug Discovery Generating Revenue 000000 0000000000
Capstan Therapeutics 20-Mar-2024 00000 00000 00000 Biotechnology Pre-Clinical Trials 000000 0000000000
Enterprise Therapeutics 26-Jan-2024 00000 00000 000.00 Drug Discovery Generating Revenue 0000 000000000 00
Aravax 23-Jan-2024 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Granite Bio 18-Oct-2023 00000 00000 0000 Biotechnology Clinical Trials - Phase 1
AstronauTx 02-Oct-2023 00000 00000 000.00 Drug Discovery Startup 00000000 00000 00.0
Hyku 19-Sep-2023 0000 00000 0000 Biotechnology Startup 00000 00000 00.0
Mediar Therapeutics 11-Sep-2023 Later Stage VC 0000 Drug Discovery Pre-Clinical Trials 0000000 00000000 00.0
Fore Bio 09-Aug-2023 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 1 000000 0000000000
You’re viewing 10 of 343 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis Venture Fund Exits (166)

Company Name Exit Date Exit Type Exit Size
Aelin Therapeutics 07-Jul-2023 Out of Business
Oculis Holding 28-Feb-2023 0000000 000000 00000
Oxagen 04-Nov-2022 0000000000: 000000
EyeSense 01-Nov-2022 000000000 00000000
Escape Bio 01-Sep-2022 0000000000: 000000
Forma Therapeutics 01-Sep-2022 000000000000000000 00.00
Kedalion Therapeutics 07-Jul-2022 000000000000000000
Viamet Pharmaceuticals Holdings 10-Jan-2022 000 00 00000000
Forendo Pharma 13-Dec-2021 Merger/Acquisition 00000
Lemonaid Health 01-Nov-2021 Merger/Acquisition 00000
You’re viewing 10 of 166 exits. Get the full list »

Novartis Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Novartis Venture Fund Management, Team & Partners (32)

Name Title Deals Funds Boards Office
Anja König Ph.D Global Head 00 0 0 Basel, Switzerland
Bart Dzikowski JD Managing Director and Head of Transactions & Legal 0 0 0 Basel, Switzerland
Aaron Nelson Ph.D Managing Director 0 0 Cambridge, MA
Beat Steffen MD Managing Director 0 0 0 Basel, Switzerland
Florian Muellershausen Ph.D Managing Director 0 0 Basel, Switzerland
You’re viewing 5 of 32 team members. Get the full list »

Novartis Venture Fund Co-Investors (179)

Name With Exits Lead Partner Series Industry
Forbion 6 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Pfizer Ventures 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
Johnson & Johnson Innovation - JJDC 0 0 0 Series chart Industry bar
You’re viewing 5 of 179 co-investors. Get the full list »

Novartis Venture Fund FAQs

  • What is Novartis Venture Fund?

    Founded in 1996, Novartis Venture Fund is a corporate venture capital investment arm of Novartis based in Basel, Switzerland.

  • When was Novartis Venture Fund founded?

    Novartis Venture Fund was founded in 1996.

  • Where is Novartis Venture Fund headquartered?

    Novartis Venture Fund is headquartered in Basel, Switzerland.

  • What is Novartis Venture Fund's total asset value?

    Novartis Venture Fund has around 00000 in total assets under management.

  • How many investments has Novartis Venture Fund made?

    Novartis Venture Fund has made 343 investments.

  • What has Novartis Venture Fund invested in?

    Novartis Venture Fund has made numerous investments in companies like FundaMental Pharma, ImmPACT Bio, and Capstan Therapeutics within the Pharmaceuticals, Drug Discovery, and Biotechnology industries.

  • What has Novartis Venture Fund invested in recently?

    Novartis Venture Fund's latest investment was on 11-Apr-2024 in FundaMental Pharma, a company within the Pharmaceuticals industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »